We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BTSG vs. CAI: Which Stock Should Value Investors Buy Now?
Read MoreHide Full Article
Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG - Free Report) or Caris Life Sciences,?Inc. (CAI - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.
Currently, BrightSpring Health Services, Inc. has a Zacks Rank of #1 (Strong Buy), while Caris Life Sciences,?Inc. has a Zacks Rank of #3 (Hold). This means that BTSG's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
BTSG currently has a forward P/E ratio of 35.08, while CAI has a forward P/E of 234.70. We also note that BTSG has a PEG ratio of 0.65. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CAI currently has a PEG ratio of 8.03.
Another notable valuation metric for BTSG is its P/B ratio of 6.14. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, CAI has a P/B of 11.15.
These metrics, and several others, help BTSG earn a Value grade of B, while CAI has been given a Value grade of D.
BTSG has seen stronger estimate revision activity and sports more attractive valuation metrics than CAI, so it seems like value investors will conclude that BTSG is the superior option right now.
View the Zacks #1 Rank List
Image: Bigstock
BTSG vs. CAI: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG - Free Report) or Caris Life Sciences,?Inc. (CAI - Free Report) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.
Currently, BrightSpring Health Services, Inc. has a Zacks Rank of #1 (Strong Buy), while Caris Life Sciences,?Inc. has a Zacks Rank of #3 (Hold). This means that BTSG's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. However, value investors will care about much more than just this.
Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
BTSG currently has a forward P/E ratio of 35.08, while CAI has a forward P/E of 234.70. We also note that BTSG has a PEG ratio of 0.65. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CAI currently has a PEG ratio of 8.03.
Another notable valuation metric for BTSG is its P/B ratio of 6.14. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, CAI has a P/B of 11.15.
These metrics, and several others, help BTSG earn a Value grade of B, while CAI has been given a Value grade of D.
BTSG has seen stronger estimate revision activity and sports more attractive valuation metrics than CAI, so it seems like value investors will conclude that BTSG is the superior option right now.